期刊文献+

角果木提取物Tagalsin对小鼠艾氏腹水瘤抑制作用的研究 被引量:5

THE INHIBITORY ACTION OF CERIOPS TAGAL EXTRACT Tagalsin ON EHRLICH ASCITES TUMOR IN MICE
下载PDF
导出
摘要 目的探讨角果木提取物Tagalsin的抗肿瘤作用及其对bcl-2/bax表达的影响,了解其抗肿瘤机制。方法建立小鼠艾氏腹水瘤实体瘤模型,随机分为5组,Tagalsin高剂量组给予Tagalsin 16.50mg/(kg.d)、中剂量组给予Tagalsin 3.30mg/(kg.d)、低剂量组给予Tagalsin 0.66mg/(kg.d),空白对照组给予等体积食用油,阳性对照组给予卡莫氟100mg/(kg.d),连续灌胃给药10d,然后分别计算各组抑瘤率、脾指数和胸腺指数,免疫组化方法检测bcl-2、bax的表达水平及其比值。结果与空白对照组比较,阳性对照组及Tagalsin各剂量组肿瘤生长缓慢(F=1 588.82,t=36.38~75.19,P<0.05),高、中、低剂量组及阳性对照组的抑瘤率分别为37.25%、34.10%、29.51%、61.03%;与空白对照组比较,阳性对照组及Tagalsin各剂量组脾指数和胸腺指数均显著降低;与阳性对照组比较,Tagalsin各剂量组胸腺指数均降低(F=95 874.12,t=2.54~474.59,P<0.05)。阳性对照组及Tagalsin各剂量组bcl-2/bax比值与空白对照组比较差异均具有显著性(F=342.89,t=23.30~47.19,P<0.05)。结论 Tagalsin可能通过下调bcl-2、上调bax的表达,从而抑制肿瘤的生长,且对小鼠的体液免疫有一定的调节作用。 Objective To explore the antitumor action of Tagalsin(extracted from Ceriops tagal) and its effect on the expression of bcl-2/bax. Methods Models of Ehrlich ascites tumor were created in rats,which were randomly divided into five groups as follows: high-dose Tagalsin(Tagalsin 16.50 mg·kg-1·d-1),moderate-dose Tagalsin(3.30 mg·kg-1·d-1),low-dose(Tagalsin 0.66 mg·kg-1·d-1),blank-control and positive control.In Tagalsin groups,a corresponding dose of Talgasin was offered;in the blank group,a same volume of edible oil was given;in positive control group,carmofur tablets 100 mg/(kg·d),which were all administrated intragastrically for 10 days.The oncostatic rate,the spleen and thymus indexes were calculated,and the expressions of bcl-2/bax detected by immunohistochemistry. Results Compared with the blank control group,the tumor grew more slowly in the positive control and different-dose Tagalsin groups(F=1 588.82,t=36.38-75.19,P〈0.05),and the oncostatic rate of the high-,middle-,low-dose and positive control group was 37.25%,34.10%,29.51%,and 61.03%,respectively.Compared with the blank control group,the indexes of spleen and thymus in the positive control and Tagalsin groups were significantly lower;compared with the positive control,the index of thymus in Tagalsin groups was lower(F=95 874.12,t=2.54-474.59,P〈0.05).The differences of the ratio of bcl-2/bax among the blank control,the positive control and Tagalsin groups were statistically significant(F=342.89,t=23.30-47.19,P〈0.05). Conclusion Tagalsin inhibits the growth of tumor by decreasing bcl-2 and increasing bax expression,which has a certain regulation action on humoral immunity in mice.
出处 《齐鲁医学杂志》 2012年第2期107-109,共3页 Medical Journal of Qilu
关键词 Tagalsin Ehrlich瘤 BCL-2 BAX Tagalsin carcinoma Ehrlich tumor bcl-2 bax
  • 相关文献

参考文献10

  • 1ANJANEYULU A S R,RAO V L.Ceripsins A-D,diterpe-noids from ceriopsdecandra[J].Phytochemistry,2002,60:777-782. 被引量:1
  • 2宋修岐,董佃国,郭云良,姚如永.海洋候选药物Tagalsin抗肝癌作用[J].中华实验外科杂志,2010(10):1554-1555. 被引量:2
  • 3白映涛,任美萍,李蓉,刘明华,肖顺汉,李茂.克癌新抗肿瘤作用机制研究[J].医学信息(中旬刊),2010,5(11):3125-3127. 被引量:1
  • 4FUKUSHIMA S,TERASAKI M,SAKATA K,et al.Sensi-tivity and usefulness of anti-phosphohistone-H3antibody im-munostaining for counting mitotic figures in meningioma cases[J].Brain Tumor Pathol,2009,26(2):51-57. 被引量:1
  • 5KORSMEYER S J,SHUTTER J R,VEIS D J,et al.Bcl-2/Bax:a rheostat that regulates an anti-oxidant pathway and celldeath[J].Semin Cancer Biol,1993,4(6):327-332. 被引量:1
  • 6MACKEY T J,BORKOWSKI A,AMIN P,et al.Bcl-2/Baxratio as a predictive marker for therapeutic response to radio-therapy in patients with prostate cancer[J].Urology,1998,52(6):1085-1090. 被引量:1
  • 7SCOPA C D,VAGIANOS C,KARDAMAKIS D,et al.Bcl-2/Bax ratio as a predictive marker for therapeutic response toradiotherapy in patients with rectal cancer[J].Appl Immuno-histochem Mol Morphol,2001,9(4):329-334. 被引量:1
  • 8NARAYAN S,CHANDRA J,SHARMA M,et al.Expres-sion of apoptosis regulators Bcl-2and Bax in childhood acutelymphoblastic leukemia[J].Hematology,2007,12(1):39-43. 被引量:1
  • 9OSHIKAWA T,OKAMOTO M,AHMED S U,et al.Therelationship between gene expression of Bcl-2and Bax and thetherapeutic effect in oral cancer patients[J].Gan To KagakuRyoho,2006,33(12):1723-1725. 被引量:1
  • 10薛茜,邹玉安,赵宝民,杨向方.康脑液1号对大鼠脑缺血再灌注半暗带细胞凋亡及Bcl-2/Bax比值的影响[J].中国全科医学,2010,13(5):498-501. 被引量:8

二级参考文献22

共引文献8

同被引文献128

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部